Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

Pfizer's 7.45% dividend yield can't offset weak growth, declining EPS, and patent risks. Read more on PFE and why analysts ...

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look.

With that in mind, let's consider two high-yield dividend stocks worth investing in: Pfizer (NYSE: PFE) and Medical ...

Consider pharmaceutical giant Pfizer (NYSE: PFE). Its dividend yield is around 7.5% right now ... Where to invest $1,000 right now? Our analyst team just revealed what they believe are the ...

But I wouldn't bet on the drugmaker's dividend yield remaining as high as it is now. A lot of negativity is baked into Pfizer's share price, with the stock trading at less than 8 times forward ...

So, is Pfizer's 7.63% dividend yield worth the effort? If I base my decision solely on a first level analysis of its past, I would say NO. Yet, investment is always about the future, not the past ...

Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. Markets expect ...

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...